Home
About
Publications Trends
Recent Publications
Expert Search
Archive
alt pathway
What is the ALT Pathway?
The
Alternative Lengthening of Telomeres (ALT)
pathway is a telomere maintenance mechanism that some cancer cells use to maintain their
telomere length
without the enzyme
telomerase
. Telomeres are the protective caps at the ends of chromosomes, and their maintenance is crucial for
cell division
and
genomic stability
. In the absence of telomere maintenance, cells would eventually reach a state called
replicative senescence
due to critically short telomeres.
Frequently asked queries:
What is the ALT Pathway?
How is the ALT Pathway Activated in Cancer?
Why is the ALT Pathway Important in Cancer?
How Can the ALT Pathway be Detected?
What are the Therapeutic Implications of Targeting the ALT Pathway?
What Challenges Exist in Targeting the ALT Pathway?
Are There Any Risks Associated with FEES?
How Have Research and Technology Improved Outcomes?
Why is Caregiver Support Important in Cancer Care?
What Is the Role of Epigenetic Modifiers?
What are the Benefits of In-Home Support?
What is Philanthropy in the Context of Cancer?
What Factors Contribute to Tumor Promotion?
What is c-Myc?
How can individuals avoid tobacco and excessive alcohol?
How is Real-Time Monitoring Conducted?
What Is the Future of Error Detection in Cancer?
How Can Telemedicine Apps Be Integrated into Traditional Cancer Care?
What is Censoring?
How to Find a Bereavement Counselor?
Follow Us
Facebook
Linkedin
Youtube
Instagram
Top Searches
Brain Tumor
Breast cancer
cancer
Cancer Genomics
Chemotherapy
hepatocellular carcinoma
Nanotechnology
Non-Hodgkin’s Lymphoma
Partnered Content Networks
Relevant Topics
4D Segmentation
Alopecia
Atlas-based Segmentation
Automated Segmentation
B-cell malignancies
biomarkers
Brain Tumor
Brain Tumor Segmentation
Breast cancer
cancer
Cancer Genome Atlas
Cancer genomics
Cancer treatment
CAR T-cell therapy
cell adhesion
cell migration
chemotherapy
Chromatin remodeling genes
CIAbimatoprost
Combination therapy
Copy number variations
cytokine release syndrome
Deep Learning
diffuse large B-cell lymphoma
docetaxel-cyclophosphamide
Drug delivery
epirubicin-cyclophosphamide
extracellular matrix
Genetic alteration
Glioblastoma
Gold nanoparticles
Hepatocellular carcinoma
High Tumor
image-guided radiotherapy
Imaging Techniques
Immunotherapy
Integrative genomics
integrin inhibitors
Integrins
Keratinocyte
Lipid-based nanoparticles
liver cancer
Machine Learning
Magnetic Resonance Imaging
metastasis
methyltransferase
MRI
Multi-modal Imaging
Mutual exclusivity analysis
Nanoparticles
Nanotechnology
neoadjuvant radiotherapy
neurotoxicity
Next-generation sequencing
nnovative Biomarkers
Non-Hodgkin’s lymphoma
Novel Biomarkers for Brain Tumors
Novel Chemotherapy
Oncogenic transcription factors
oncological diseases
paclitaxel
Personalized medicine
Photobiomodulation therapy
Polymeric nanoparticles
portal vein tumor thrombus
Probabilistic Models
radiotherapy
refractory lymphoma
relapsed lymphoma
Silver nanoparticles
stereotactic body radiation therapy
Targeted therapy
Tolerability
transarterial chemoembolization
tumor microenvironment
tumor progression
Voltage-gated sodium channels
Subscribe to our Newsletter
Stay updated with our latest news and offers related to Cancer.
Subscribe